BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The proposed research aims to compare between BeEAM standard regimen and CEM as conditioning
regimen in lymphoma patients in safety profile& toxicity, infections (Febrile neutropenia)
during transplant, time to engraftment (recovery not neutropenic), Length of stay at
hospital, time to relapse, and other complications.